3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM)

Gregorc, V ; Gaafar, R ; Favaretto, A ; Grossi, F ; Jassem, J ; Polychronis, A ; Bidoli, P ; Tiseo, M ; O'Brien, M ; Shah, R ; Taylor, P ; Novello, S ; Muzio, A ; Bearz, A ; Badurak, P ; Greillier, L ; Fontana, F ; Colombi, S ; Lambiase, A ; Bordignon, C

European journal of cancer (1990), 2015-09, Vol.51, p.S634-S634 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível